New study boasts 90% accuracy when using PARR to diagnose canine lymphoma

August 7, 2019

Article originally published in NEWStat, an American Animal Hospital Association Publication  Written by Tony McReynolds Who measures the measurements? Who diagnoses the diagnostics? In short, who assays the assays? Veterinarians have been using polymerase chain reaction for antigen receptor rearrangement (PARR), a readily available molecular assay that helps diagnose some kinds of canine lymphoma, for years.

Read More
  • AAHA, VetBloom To Launch Exclusive AAHA Member Learning Platform

    April 30, 2019

    LAKEWOOD, Colorado – April 30, 2019 – In a move that brings a veterinary industry leader in online CE together with the only association to accredit companion animal hospitals in North America, VetBloom and the American Animal Hospital Association (AAHA) are excited to announce the upcoming launch of the AAHA | Learning platform. Provided as an exclusive AAHA member benefit, the new platform

    Read More
  • Ethos Veterinary Health LLC Recapitalization With Brown Brothers Harriman Capital Partners

    January 17, 2019

    Brown Brothers Harriman Completes Investment in Ethos Veterinary Health LLC New York, NY, JANUARY 9, 2019 – BBH Capital Partners (“BBHCP”) announced today that it has completed a recapitalization of Ethos Veterinary Health LLC (“Ethos” or the “Company”). Headquartered in Woburn, Massachusetts, Ethos is one of the largest pure-play independent providers of specialty veterinary health services, including 24/7

    Read More
  • First-Ever, Nationwide, Multicenter, Prospective Study Of Canine Splenic Hemangiosarcoma

    January 15, 2019

    Cutting Edge Cancer Research in Veterinary Specialty Practice: Ethos Veterinary Health Completes First-Ever, Nationwide, Multicenter, Prospective Study of Canine Splenic Hemangiosarcoma Woburn, Mass. — Jan. 15, 2019 — Ethos Veterinary Health (Ethos) has completed the patient accrual phase of their new Canine Hemangiosarcoma Molecular Profiling (CHAMP) study. Hemangiosarcoma is one of the most malignant forms of cancer in dogs and CHAMP

    Read More
  • Western Reserve Partners Advises Ethos Veterinary Health

    December 18, 2018

    Western Reserve Partners, a division of Citizens Capital Markets, Inc., is pleased to announce that it served as the exclusive financial advisor to Ethos Veterinary Health, LLC (“Ethos” or the “Company”) in its recapitalization by Brown Brothers Harriman Capital Partners (“BBHCP”).

    Read More
  • Ethos Supports Initiative to Establish Standard Title and Scope of Practice for Veterinary Technicians

    September 5, 2018

    Woburn, Mass., August 24, 2018 –Ethos Veterinary Health (Ethos) has developed a position statement in support of NAVTA’s Veterinary Nurse Initiative (VNI). The initiative by the National Association of Veterinary Technicians in America is aimed at establishing a national credential for Registered Veterinary Nurses (RVN).

    Read More
  • Ethos Continues To Show Strong Growth in Q1 2018

    June 15, 2018

    WOBURN, Mass. (BUSINESS WIRE) — Ethos Veterinary Health (Ethos), a leading independent veterinary health company, just finalized its third acquisition since December 2017, expanding its presence across the U.S. Integrative Pet Care in Chicago, Veterinary Emergency + Referral Center of Hawaii, in Honolulu, and Atlantic Street Veterinary Hospital Pet Emergency Center in Roseville, CA, have recently joined Ethos. Ethos has significantly expanded

    Read More
  • The American College of Veterinary Internal Medicine and VetBloom Enter into Unique Partnership

    June 12, 2018

    WOBURN, Mass.–(BUSINESS WIRE)–The American College of Veterinary Internal Medicine (ACVIM) has entered into a partnership with VetBloom, the digital learning ecosystem from Ethos Veterinary Health (Ethos). This multifaceted partnership will actualize development of a Virtual Learning Environment for ACVIM and its members and allow collaboration on the development of eLearning modules. In addition, VetBloom will develop an integrated online

    Read More
  • LexaGene Announces Collaboration with Ethos Veterinary Health

    April 4, 2018

    BEVERLY, Mass., April 04, 2018 (GLOBE NEWSWIRE) — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into collaboration with Ethos Veterinary Health, a veterinary health company with hospitals across the U.S. that provide advanced medical care for pets. This partnership will provide canine urine

    Read More
  • LMU and Ethos Veterinary Health Collaborate on Research, Simulation, and Technology

    March 20, 2018

    WOBURN, Mass.–(BUSINESS WIRE)–Lincoln Memorial University (LMU) and Ethos Veterinary Health (Ethos) have entered into a unique collaborative relationship to advance their shared commitment to improve the profession through innovation in education. The relationship aims to transform learning in the veterinary community by leveraging Ethos’ unique commitment to learning and development and its online learning platform, VetBloom, and the strength

    Read More
  • CNA Diagnostics and Ethos Enter Strategic Partnership to Develop Suite of Diagnostic Tests for the Companion Animal Market

    February 28, 2018

    CNA Diagnostics Inc. (“CNAD”) and Ethos Veterinary Health (“Ethos”) are pleased to announce the parties have entered a strategic partnership to develop and distribute a suite of molecular diagnostic tests specifically designed to serve the companion animal market.

    Read More
  • VetDC Announces New TANOVEA®-CA1 Publication and State of the Art Presentation at the Veterinary Cancer Society 2017 Annual Conference

    November 3, 2017

    FORT COLLINS, Colo.–(BUSINESS WIRE)–VetDC, Inc., the leading veterinary cancer therapeutics company, today announced a new TANOVEA®-CA1 (rabacfosadine for injection) publication in Veterinary & Comparative Oncology. Data from this publication and several new VetDC-sponsored studies was prominently featured in a State of the Art presentation at the Veterinary Cancer Society (VCS) Annual Conference this past weekend in Portland, Oregon,

    Read More
  • Puppy Overdoses After Ingesting Opioid

    October 26, 2017

    For veterinarians, this is no more shocking than any other toxin or item that pets can get exposed to. Neither is the location of the exposure, as no town is immune from the opioid crisis. Naloxone is not a new addition to our hospital formularies, as opioids are utilized in anesthesia and pain management protocols, and this agent has long been used to reverse these effects when needed.

    Read More
Load More
Loading